References
- Brambilla G, Martelli A (1993). Human hepatocyte primary cultures in toxicity assessment. Cytotechnol, 11, 6-8. https://doi.org/10.1007/BF00746040
- Capurro M, Wanless IR, Sherman M, et al (2003). Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterol, 125, 89. https://doi.org/10.1016/S0016-5085(03)00689-9
- Fausto N, Campbell JS (2010). Mouse models of hepatocellular carcinoma. In Seminars in liver disease, 30, 87-98.
- Filmus J, Church J, Buick R (1988). Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine. Mol Cell Biol, 8, 4243-9. https://doi.org/10.1128/MCB.8.10.4243
- Gomez-Lechon MJ, Castell JV, Donato MT (2010). The use of hepatocytes to investigate drug toxicity. In Hepatocytes, 640, 389-415. https://doi.org/10.1007/978-1-60761-688-7_21
- Greenhough S, Medine CN, Hay DC (2010). Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening. Toxicol, 278, 250-5. https://doi.org/10.1016/j.tox.2010.07.012
- Grozdanov PN, Yovchev MI, Dabeva MD (2006). The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells. Lab Invest, 86, 1272-84. https://doi.org/10.1038/labinvest.3700479
- Guillouzo A, Morel F, Fardel O, Meunier B (1993). Use of human hepatocyte cultures for drug metabolism studies. Toxicology, 82, 209-19. https://doi.org/10.1016/0300-483X(93)90065-Z
- Hamazaki T, Iiboshi Y, Oka M, et al (2001). Hepatic maturation in differentiating embryonic stem cells in vitro. FEBS letters, 497, 15-9. https://doi.org/10.1016/S0014-5793(01)02423-1
- Hammond AH, Garle MJ, Fry JR (1995). Mechanism of toxicity of precocene II in rat hepatocyte cultures. J Biochem Toxicol, 10, 265-73. https://doi.org/10.1002/jbt.2570100507
- Ho DW, Yang ZF, Yi K, et al (2012). Gene expression profiling of liver cancer stem cells by RNA-sequencing. PloS one, 7, 37159. https://doi.org/10.1371/journal.pone.0037159
- Kafert-Kasting S, Alexandrova K, Barthold M, et al (2006). Enzyme induction in cryopreserved human hepatocyte cultures. Toxicol, 220, 117-25. https://doi.org/10.1016/j.tox.2005.12.013
- Kandil DH, Cooper K (2009). Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more. Adv Anat Pathol, 16, 125-9. https://doi.org/10.1097/PAP.0b013e3181992455
- Kang S-J, Jeong S-H, Kim E-J, et al (2013). Evaluation of hepatotoxicity of chemicals using hepatic progenitor and hepatocyte-like cells derived from mouse embryonic stem cells. Cell biol and toxicol, 29, 1-11. https://doi.org/10.1007/s10565-012-9223-0
- Maier P (1989). Development of hepatocyte cultures in toxicity testing. Altex, 6, 38.
- Nakatsura T, Yoshitake Y, Senju S, et al (2003). Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem Bioph Res Commun, 306, 16-25. https://doi.org/10.1016/S0006-291X(03)00908-2
- Nussler A, Wang A, Neuhaus P, et al (2001). The suitability of hepatocyte culture models to study various aspects of drug metabolism. Altex, 18, 91.
- Okura H, Komoda H, Saga A, et al (2009). Properties of hepatocyte-like cell clusters from human adipose tissue-derived mesenchymal stem cells. Tissue Eng Part C Methods, 16, 761-70.
- Rambhatla L, Chiu C-P, Kundu P, et al (2003). Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant, 12, 1-11. https://doi.org/10.3727/000000003783985179
- Ratanasavanh D, Baffet G, Latinier M, et al (1988). Use of hepatocyte co-cultures in the assessment of drug toxicity from chronic exposure. Xenobiotica, 18, 765-71. https://doi.org/10.3109/00498258809041715
- Reich-Slotky R, Bonneh-Barkay D, Shaoul E, et al (1994). Differential effect of cell-associated heparan sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptor. J Biol Chem, 269, 32279-85.
- Sell S, Dunsford HA (1989). Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. The Am J Pathol, 134, 1347-63.
- Shirakawa H, Kuronuma T, Nishimura Y, et al (2009a). Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer. Int J Oncol, 34, 649-56.
- Shirakawa H, Suzuki H, Shimomura M, et al (2009b). Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma. Cancer Sci, 100, 1403-7. https://doi.org/10.1111/j.1349-7006.2009.01206.x
- Song HH, Shi W, Filmus J (1997). OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2. J Biol Chem, 272, 7574-7. https://doi.org/10.1074/jbc.272.12.7574
- Stefaniuk P, Cianciara J, Wiercinska-Drapalo A (2010). Present and future possibilities for early diagnosis of hepatocellular carcinoma. World J Gastroentero, 16, 418. https://doi.org/10.3748/wjg.v16.i4.418
- Sung YK, Hwang SY, Park MK, et al (2003). Glypican-3 is overexpressed in human hepatocellular carcinoma. Cancer Science, 94, 259-62. https://doi.org/10.1111/j.1349-7006.2003.tb01430.x
- Touboul T, Hannan NR, Corbineau S, et al (2010). Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology, 51, 1754-65. https://doi.org/10.1002/hep.23506
- Vesselinovitch S, Koka M, Mihailovich N, Rao K (1984). Carcinogenicity of diethylnitrosamine in newborn, infant, and adult mice. J Cancer Res Clin Oncol, 108, 60-5. https://doi.org/10.1007/BF00390974
- Visvader JE, Lindeman GJ (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature reviews. Cancer, 8, 755-68.
- Yao M, Yao DF, Bian YZ, et al (2011). Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma. HBPD INT, 10, 289-94.
Cited by
- Expression of Glypican-3 is Highly Associated with Pediatric Hepatoblastoma: a Systemic Analysis vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1029
- The significance of glypican-3 expression profiling in the tumor cellular origin theoretical system for hepatocellular carcinoma progression vol.32, pp.8, 2017, https://doi.org/10.1111/jgh.13736
- Simple Risk Score for Prediction of Early Recurrence of Hepatocellular Carcinoma within the Milan Criteria after Orthotopic Liver Transplantation vol.7, pp.1, 2017, https://doi.org/10.1038/srep44036